Frequency of a mutated CCR-5 allele (Δ32) among Italian healthy donors and individuals at risk of parenteral HIV infection

AIDS Research and Human Retroviruses

Volumn 15, Issue 4, 1999, Pages 337-344

  Zamarchi, Rita ^a   Indraccolo, Stefano ^a,b   Minuzzo, Sonia ^a   Coppola, Vincenzo ^a   Gringeri, Alessandro ^c   Santagostino, Elena ^c   Vicenzi, Elisa ^d   De Silvestro, Giustina ^e   Biagiotti, Roberta ^f   Baldassarre, Clara ^g   Chieco Bianchi, Luigi ^a   Amadori, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b IST Biotechnology Section   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d AIDS Immunopathogenesis Unit   (Italy)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g ULSS 38   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; VIRUS RNA;

ALLELE; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; GENE MUTATION; GENOTYPE; HEMOPHILIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0033045484     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311303     Document Type: Article

References (37)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
2. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
3. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau N: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996; 381:661-666.
4. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, and Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85: 1149-1158.
5. + cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381:667-673.
6. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry co-factor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
7. Dittmar MT, McKnight A, Simmons G, Clapham PR, Weiss RA, and Simmonds P: HIV-1 tropism and co-receptor use. Nature (London) 1997;385:495-496.
8. Zhang L, Huang Y, He T, Cao Y, and Ho DD: HIV-1 subtype and second-receptor use. Nature (London) 1996;383:768.
9. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, and Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp med 1997;185: 1681-1691.
10. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, and Parmentier M: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (London) 1996;382:722-725.
11. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, and Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-1243.
12. Martinson JJ, Chapman NH, Rees DC, Liu YT, and Clegg JB: Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet 1997;16:100-103.
13. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, and Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86: 367-377.
14. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, and O'Brien SJ: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-1862.
15. Biti R, French R, Young J, Bennetts B, Stewart G, and Liang T: HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Med 1997;3:252-253.
16. O'Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, Michael NL, and White GC: HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 1997;349:1219.
17. Theodorou I, Meyer L, Magierowska M, Katlama C, and Rouzioux C: HIV-1 infection in an individual homozygous for CCR5 delta 32. SEROCO Study Group. Lancet 1997;349:1219-1220.
18. Balotta C, Bagnarelli P, Violin M, Ridolfo AL, Zhou D, Berlusconi A, Corvasce S, Corbellino M, Clementi M, Clerici M, Moroni M, and Galli M: Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 1997;11:F67-F71.
19. Schrager LK, Young JM, Fowler MG, Mathieson BJ, and Vermund SH: Long-term survivors of HIV-1 infection: Definition and research challenges. AIDS 1994;8:S95-S108.
20. Strathdee SA, Veugelers PJ, Page Shafer KA, McNulty A, Moss AR, Schechter MT, van Griensven GJ, and Coutinho RA: Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS 1996;10:959-965.
21. Sagliocca L, Rezza G, Vlahov D, Baldassarre C, Siconolfi M, Nespoli M, and Carrieri P: A morphin prescription program in Italy (1980-1995): Retrospective evidence of protection against HIV/ AIDS. Addict Res 1997;5:137-144.
22. Amadori A, Zamarchi R, Ciminale V, Del Mistro A, Siervo S, Alberti A, Colombatti M, and Chieco Bianchi L: HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol 1989;143:2146-2152.
23. Indraccolo S, Simon M, Hehlmann R, Erfle V, Chieco-Bianchi L, and Leib-Moesch C: Genetic instability of a dinucleotide repeat-rich region in three hematologic malignancies. Leukemia 1995;9: 1517-1522.
24. Vicenzi E, Bagnarelli P, Santagostino E, Ghezzi S, Alfano M, Sinnone MS, Fabio G, Turchetto L, Moretti G, Lazzarin A, Mantovani A, Mannucci PM, Clementi M, Gringeri A, and Poli G: Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood 1997;89:191-200.
25. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, Clementi M, and Chieco Bianchi L: Genetic control of the CD4/CD8 T-cell ratio in humans. Nature Med 1995;1: 1279-1283.
26. Dodd RY: The risk of transfusion-transmitted infection. N Engl J Med 1992;327:419-421.
27. Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, and Zimmerman TS: Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: Implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982;59:1272-1278.
28. Centers for Disease Control and Prevention: MMWR 1992;41:RR-17.
29. Franceschi S, Dal Maso L, and La Vecchia C: Trends in incidence of AIDS associated with transfusion of blood and blood products in Europe and United States, 1985-93. Br Med J 1995;311: 1534-1536.
30. Smith MW, Dean M, Carrington M, Winkler C. Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, and O'Brien SJ: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277: 959-965.
31. Montagna M, Santacatterina M, Corneo B, Menin C, Serova O, Lenoir GM, Chieco Bianchi L, and D'Andrea E: Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res 1996;56:5466-5469.
32. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, MACS, and Murphy PM: CCR5 promoter polymorphism and HIV-1 disease progression. Lancet 1998;352:866-870.
33. Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy JF, and Theodorou I: Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: Relationship with viral load. The SEROCO Study Group. AIDS 1997;11:F73-F78.
34. Eugen-Olsen J, Iversen AK, Garred P, Koppelhus U, Pedersen C, Benfield TL, Sorensen AM, Katzenstein T, Dickmeiss E, Gerstoft J, Skinhoj P, Svejgaard A, Nielsen JO, and Hofmann B: Heterozygosity for a deletion in the CKR-5 gene loads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997;11:305-310.
35. Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, and Sheppard HW: The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997;3:338-340.
36. Cocchi F, De Vico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1α and MIP-1β as the major immunosuppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
37. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, O'Brien SJ, Burny A, and Gallo RC: C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci USA 1998;95:3857-3861.